Pembrolizumab‐induced pancytopenia in a patient with squamous cell lung cancer

Immune checkpoint inhibitors (ICIs) are reportedly effective against many kinds of neoplasm, but may be responsible for several kinds of immune‐related adverse events (irAEs). Among these irAEs, the incidence of myelosuppression due to ICIs is relatively low. Corticosteroids are needed to control mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueki, Yuriko, Suzuki, Manabu, Horikawa, Yuriko, Watanabe, Hiromu, Yamaguchi, Yoh, Morita, Chie, Tsukada, Akinari, Takumida, Hiroshi, Kusaba, Yusaku, Katsuno, Takashi, Tsujimoto, Yoshie, Sakamoto, Keita, Hashimoto, Masao, Terada, Junko, Ishii, Satoru, Takasaki, Jin, Naka, Go, Iikura, Motoyasu, Izumi, Shinyu, Takeda, Yuichiro, Hojo, Masayuki, Sugiyama, Haruhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471020/
https://www.ncbi.nlm.nih.gov/pubmed/32767641
http://dx.doi.org/10.1111/1759-7714.13582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471020/
https://www.ncbi.nlm.nih.gov/pubmed/32767641
http://dx.doi.org/10.1111/1759-7714.13582

Ejemplares similares